Business Wire

Security Vulnerability Concerns Skyrocket as Neustar’s International Cyber Benchmark Index™ Hits Record High

Jaa

Neustar®, Inc., a trusted, neutral provider of real-time information services, today released two new cybersecurity reports, reconfirming the need to take action in the face of increasing cyber threats. Both reports, The International Cyber Benchmarks Index and The Changing Face of Cyber Attacks, highlight that IT security professionals are more than twice as worried about data breaches and cyber-attacks today than they were this time last year.

The International Cyber Benchmarks Index is an initiative of the Neustar International Security Council (NISC), an elite group of select cyber security leaders across key industries, that assesses the international cybersecurity landscape from the vantage point of security professionals across the EMEA and U.S. regions. Other key findings from the most recent survey include:

  • Greatest Threats: System compromises and ransomware are the greatest threats to organizations – with 20 percent listing both as their primary concern – closely followed by Distributed Denial of Service (DDoS) attacks (19 percent), financial theft (18 percent), and attacks on intellectual property (17 percent).
  • Increasing Concern: 47 percent of security professionals see DDoS attacks as increasingly harmful to their organization this year, compared to 38 percent last year.
  • No Sign of Slowing Down: 98 percent of companies surveyed have taken steps to minimize risks from the Meltdown-Spectre attack; nine out of ten respondents believe that these attacks will become the norm.
  • Time to Mitigate: In 2017, half of the respondents claimed it would take them between 60 seconds and five minutes to act on an attack, with a quarter claiming it would only take 60 seconds, and the final 25 percent pushing the five-minute mark. Comparing this data to 2018, the clear majority (68 percent) still sit between 60 seconds and five minutes.

These numbers mirror data in Neustar's The Changing Face of Cyber Attacks report, which examined the effects of Memcached attacks and the largest DDoS attack ever recorded at 1.7Tbps. The study demonstrates how the different types of threats propagating today, combined with the sheer volume of attacks, can paint a discouraging picture. Even more alarming, however, is the fact that today’s threats seldom occur in isolation. For example, a DDoS threat in one segment can divert attention from malware in another, while ransomware can be used to hasten data exfiltration. Additional results show:

  • IPv6 attacks will rise as companies adopt the new standard. Neustar thwarted what is believed to be the first IPv6 attack –the attack presented a new direction that attackers are likely to pursue as more and more companies adopt IPv6 and run dual IPv4/IPv6 stacks.
  • IoT growth is paving the way for botnets, which are constantly evolving. Cyber criminals can rent or purchase these botnets with ease – making these threats one of the biggest issues for enterprises today.

Rodney Joffe, Head of NISC and Neustar Senior Vice President and Fellow, said, “While naturally distressing, these results should come as no surprise to anyone. Yes, security professionals are becoming more concerned about the level of threat to their organizations, because that same level of threat is continuing to rise at an extreme rate.”

“As we have seen over the past year, there are more threats to be aware of, whether in the form of DDoS, malware, application layer attacks or something else entirely, leaving professionals confused about where the next attack is coming from.”

“To successfully prepare for a cyber-attack in today’s landscape is to accept that your organization will be the next target. If you are online, you are susceptible to an attack. Whether you are most vulnerable or not is entirely up to you.”

About Neustar, Inc.

Neustar, Inc. is a leading global information services provider driving the connected world forward with responsible identity resolution. As a company built on a foundation of Privacy by Design, Neustar is depended upon by the world’s largest corporations to help grow, guard and guide their businesses with the most complete understanding of how to connect people, places and things. Neustar’s unique, accurate and real-time identity system, continuously corroborated through billions of transactions, empowers critical decisions across our clients’ enterprise needs. More information is available at https://www.home.neustar.

Contact information

Neustar Media Contact
Emma Yousif (Hotwire Global on behalf of Neustar)
neustar@Hotwireglobal.com
+44 (0) 207 608 4645

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Biogen and Samsung Bioepis Announce European Launch of IMRALDI™(adalimumab), Solidifying Leadership in European Anti-TNF Market17.10.2018 09:18Tiedote

Biogen (Nasdaq:BIIB) and Samsung Bioepis Co., Ltd. today announced the European launch of IMRALDI™ (adalimumab), a biosimilar referencing HUMIRA®. Starting today, IMRALDI™ will begin launching in major markets across Europe. The launch of IMRALDI™ marks a significant milestone for Biogen and Samsung Bioepis, as the adalimumab product is the third anti-TNF biosimilar developed by Samsung Bioepis to be commercialized by Biogen across Europe. BENEPALI™ (etanercept) and FLIXABI™ (infliximab) were approved in 2016, and have approximately 100,000 patients currently under treatment with more than 6 million doses administered across 25 and 14 countries, respectively.ii “We look forward to increasing patient access to this important medicine by leveraging our industry-leading position in the European anti-TNF market,” said Ian Henshaw, Head of Biogen’s Biosimilars Unit. “The launch of IMRALDI marks what we believe to be a landmark moment for Biogen and Samsung Bioepis and for European healthcar

Durabook Delivers World’s Toughest Semi-Rugged Computer17.10.2018 09:00Tiedote

Durabook, the global brand fully owned by Twinhead International Corporation, has today introduced the most durable semi-rugged computer ever created. The Durabook S14I greatly exceeds all existing devices in its class in both drop height and IP ratings. Built with 8th generation Intel® CPU and a wide selection of I/O options, the S14I is ideal for demanding working environments of public safety, government, military and field service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016006151/en/ Durabook S14I Features Class-Leading Drop Height and IP Ratings along with 8th Generation Intel CPU Power (Photo: Business Wire) “As the definition of the modern workplace expands, the line between what is office and what is field are often becoming blended” said Fred Kao, CEO of Twinhead. “So we are blending the line between what is a semi-rugged and what is a fully-rugged. Under the form factor of a traditional semi-rugged lapto

DIA Drives Debates and Solutions at the Crossroads of Healthcare17.10.2018 09:00Tiedote

DIA, founded as the Drug Information Association, announced three keynote speakers for the upcoming DIA Europe 2019 annual meeting: Dave deBronkart, ‘e-Patient Dave’; Hans Lehrach, Director at the Max Planck Institute for Molecular Genetics; and Kristel Van der Elst, CEO, The Global Foresight Group. The diversity of experience brought by these three leaders is reflective of the meeting mission to ensure industry, payers, patients, and regulators all have an equal voice in the debates advancing regulatory science and access to healthcare. These keynote speakers will join 300 speakers in more than 80 sessions, across seven thought leadership streams to drive collaborative answers in medicines development and access to healthcare. Highlights from sessions include Guido Rasi, Executive Director, EMA, will present first look strategies for 2021-2025 during the European Regulatory Town Hall and Niklas Hedberg, Chair EUnetHTA Executive Board, will feature case studies of Real World Evidence i

SailPoint’s Latest SaaS Release Makes Security and Compliance Accessible to All Enterprises17.10.2018 08:01Tiedote

SailPoint Technologies Holdings, Inc. (NYSE: SAIL), the leader in enterprise identity governance, unveiled a series of new innovations in IdentityNow, the industry’s most comprehensive SaaS identity governance platform. Enhancements have been made with an eye towards both closing security and compliance gaps and simplifying identity implementations for organizations who may not have dedicated identity teams and resources. New in IdentityNow is the Dynamic Discovery Engine, an innovation that allows users to easily and quickly create policies, access reviews, dashboards and reporting. As a result, IdentityNow customers are better able to address the mounting security and compliance challenges that all enterprises face today. “When we started our identity governance journey, a key requirement for us was the ability to automate identity processes where we could, while improving our audit and compliance track record,” said Michael Boucher, Sr. Director, Information Risk Management, FTD. “W

Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health17.10.2018 08:00Tiedote

Ferring Pharmaceuticals and Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016005907/en/ Evotec will apply its drug discovery platform to design novel and efficacious treatments in partnership with Ferring. The multi-target, multi-year collaboration aims to deliver small molecule pre-clinical development (PDC) and investigational new drug (IND) ready candidates. As part of the alliance, Evotec is eligible for undisclosed research funding and milestones. “To achieve leadership in reproductive medicine and women’s health, we are expanding beyond our historical expertise in peptides and tackling molecular targets that are best addressed using small molecule therapeutics,” said Per Fal

IWBI Launches Global Network of Advisors for WELL Portfolio16.10.2018 21:00Tiedote

The International WELL Building Institute™ (IWBI™) today announced the formation of a global advisory to help shape and advance the implementation of the WELL Portfolio™ Pathway pilot, a new streamlined pathway for WELL Certification™ for multiple new or existing buildings and tenant spaces in a single portfolio. WELL Portfolio, announced this past month, is being released as part of the WELL v2™ pilot, the latest iteration of the WELL Building Standard™ (WELL™). It is part of a suite of enhancements to WELL that addresses growing demand across the building industry for a program that helps owners, developers and tenants streamline and scale health and wellness upgrades to their real estate assets. The advisory includes a collection of professionals, practitioners and experts across a range of industries and sectors, each serving a one-year term. “Since we launched WELL, we’ve seen an explosion of interest from global companies to bring the same health and wellness benefits across thei

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme